Literature DB >> 14659308

Breast cancer in young women: clinicopathological features and biological specificity.

A Sidoni1, A Cavaliere, G Bellezza, M Scheibel, E Bucciarelli.   

Abstract

Literature data suggest that breast cancers occurring in young patients may be different from those arising in older women. In this study the clinicopathologic characteristics of 50 patients under 40 years of age were compared with those of patients aged over 60. Patients under 40 years old more frequently had a family history of breast cancer than did older patients (24% vs 17%) and had more often used oral contraceptives (29% vs 13%); on average they had experienced menarche 1 year earlier. For early onset breast carcinomas there was a higher frequency of grade 3 tumours (38% vs 17%) and oestrogen receptor negativity (46% vs 20%). In addition, in younger patients the carcinomas were mostly DNA aneuploid (78% vs 58%), with a higher proliferation rate (48% vs 26%) and more frequent c-erbB-2 overexpression (48% vs 26%) and p53 alteration (30% vs 8%). Our data demonstrate that breast cancers arising in young women have a significantly different biopathological profile from those in older patients, with a predominance of unfavourable prognostic parameters.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14659308     DOI: 10.1016/s0960-9776(03)00095-x

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  30 in total

1.  Determination of the prognostic value of preoperative CA15-3 and CEA in predicting the prognosis of young patients with breast cancer.

Authors:  Xuan Li; Danian Dai; Bo Chen; Hailin Tang; Xiaoming Xie; Weidong Wei
Journal:  Oncol Lett       Date:  2018-07-17       Impact factor: 2.967

Review 2.  Breast cancer in young women in southern Tunisia: Anatomical study and clinical prognostic factors: About a series of 83 patients.

Authors:  Mouna Kallel; Fatma Elloumi; Abdelmajid Khabir; Lilia Ghorbal; Souhir Chaabouni; Habib Amouri; Mounir Frikha; Jamel Daoud
Journal:  Rep Pract Oncol Radiother       Date:  2015-03-06

3.  Her-2 prognostic value in very early-stage breast cancer: a single-institution retrospective analysis.

Authors:  Pietro Sanpaolo; Viviana Barbieri; Piernicola Pedicini; Vincenzo Fusco
Journal:  Med Oncol       Date:  2011-02-26       Impact factor: 3.064

4.  The correlation of mammographic-and histologic patterns of breast cancers in BRCA1 gene mutation carriers, compared to age-matched sporadic controls.

Authors:  R Kaas; R Kroger; J L Peterse; A A M Hart; S H Muller
Journal:  Eur Radiol       Date:  2006-08-19       Impact factor: 5.315

5.  Her-2/neu expression as a predictive factor for response to anthracycline-based chemotherapy in a mexican population of locally advanced breast cancer patients.

Authors:  David Muñoz-Gonzalez; Isabel Zeichner-Gancz; Myrna Candelaria; Maria Teresa Ramirez-Ugalde; Manuel Perez-Sanchez; Guadalupe Cervantes-Vazquez; David Cantu-de Leon; Arcelia Mora-Tizcareño; Julio Leonor-Ortíz
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

6.  (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.

Authors:  Gary A Ulaner; Raychel Castillo; Debra A Goldman; Jonathan Wills; Christopher C Riedl; Katja Pinker-Domenig; Maxine S Jochelson; Mithat Gönen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-30       Impact factor: 9.236

7.  Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancer.

Authors:  Beth O Van Emburgh; Jennifer J Hu; Edward A Levine; Libyadda J Mosley; Nancy D Perrier; Rita I Freimanis; Glenn O Allen; Peter Rubin; Gary B Sherrill; Cindy S Shaw; Lisa A Carey; Lynda R Sawyer; Mark Steven Miller
Journal:  Oncol Rep       Date:  2008-05       Impact factor: 3.906

8.  Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years.

Authors:  Christopher C Riedl; Elina Slobod; Maxine Jochelson; Monica Morrow; Debra A Goldman; Mithat Gonen; Wolfgang A Weber; Gary A Ulaner
Journal:  J Nucl Med       Date:  2014-09-11       Impact factor: 10.057

9.  Clinicopathologic breast cancer characteristics: predictions using global textural features of the ipsilateral breast mammogram.

Authors:  Ibrahem H Kanbayti; William I D Rae; Mark F McEntee; Ziba Gandomkar; Ernest U Ekpo
Journal:  Radiol Phys Technol       Date:  2021-06-02

10.  Polymorphisms in drug metabolism genes, smoking, and p53 mutations in breast cancer.

Authors:  Beth O Van Emburgh; Jennifer J Hu; Edward A Levine; Libyadda J Mosley; L Douglas Case; Hui-Yi Lin; Sommer N Knight; Nancy D Perrier; Peter Rubin; Gary B Sherrill; Cindy S Shaw; Lisa A Carey; Lynda R Sawyer; Glenn O Allen; Clara Milikowski; Mark C Willingham; Mark Steven Miller
Journal:  Mol Carcinog       Date:  2008-02       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.